Innate Pharma to Participate in Upcoming Investor Conferences

On January 3, 2022 Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") reported that the Company will participate in the following upcoming virtual investor conferences (Press release, Innate Pharma, JAN 3, 2022, View Source [SID1234597983]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

ODDO BHF Digital Forum
Event Date: January 6, 2022
H.C. Wainwright BIOCONNECT Virtual Conference
Fireside Chat: January 10, 2022
Innate Pharma Virtual Corporate Access Event
Event Date: January 10-13, 2022